Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Clearside Biomedical, Inc.: Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® | 2 | GlobeNewswire (USA) | ||
16.05. | Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying | 3 | Benzinga.com | ||
10.05. | Earnings call: Clearside Biomedical updates on Q1 2024 and future plans | 1 | Investing.com | ||
10.05. | Clearside Biomedical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
10.05. | Clearside Biomedical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
09.05. | Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M | 1 | Seeking Alpha | ||
09.05. | Clearside Biomedical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.05. | Clearside Biomedical Q1 2024 Earnings Preview | 1 | Seeking Alpha | ||
08.05. | Clearside Biomedical, Inc.: Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference | 1 | GlobeNewswire (USA) | ||
30.04. | Clearside Biomedical, Inc.: Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 | 1 | GlobeNewswire (USA) | ||
16.04. | Clearside Biomedical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
16.04. | Clearside Biomedical, Inc.: Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors | 1 | GlobeNewswire (USA) | ||
02.04. | Clearside Biomedical, Inc.: Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference | 1 | GlobeNewswire (USA) | ||
18.03. | Clearside Biomedical appoints Chong as CMO | 2 | Seeking Alpha | ||
18.03. | Clearside Biomedical, Inc.: Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | 549 | GlobeNewswire (Europe) | ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through... ► Artikel lesen | |
13.03. | Earnings call: Clearside Biomedical reports on clinical trials and collaborations | 5 | Investing.com | ||
12.03. | Clearside Biomedical Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
12.03. | Clearside Biomedical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
12.03. | Clearside Biomedical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
12.03. | Clearside Biomedical, Inc.: Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | 37 | GlobeNewswire (Europe) | - Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector® - - Strengthened... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 11.138 |
EVOTEC | 5.593 |
NEL | 5.326 |
PLUG POWER | 2.984 |
TUI | 2.888 |
GAMESTOP | 2.378 |
BIONTECH | 2.377 |
BAYER | 2.027 |
SUPER MICRO COMPUTER | 1.818 |
RHEINMETALL | 1.640 |
JINKOSOLAR | 1.583 |
VOLKSWAGEN | 1.317 |
AIXTRON SE | 1.270 |
MERCEDES-BENZ | 1.224 |
TESLA | 1.223 |
SIEMENS ENERGY | 1.213 |
DEUTSCHE LUFTHANSA | 1.205 |
CUREVAC | 1.202 |
DEUTSCHE BANK | 1.191 |
BYD | 1.160 |
RENK GROUP | 1.103 |
COMMERZBANK | 1.085 |
MICROSOFT | 995 |
REDCARE PHARMACY | 943 |
INFINEON | 917 |